Dr. Bruce A. Fine, M.D.
Gynecologic Oncology (Gynecologic Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 118
Licensed in Texas since 1989, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: University of Texas Medical Branch at Galveston
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gynecologic Oncology Physician primary
TX license H6217 (first issued 1989; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical City Plano Plano, TX
- Medical City Dallas Hospital Dallas, TX
Medical groups
- Texas Oncology PA (1,014 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 118
- Services billed
- 5,441
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,995 | 19 |
| Insertion of needle into vein for collection of blood sample | 271 | 97 |
| Established patient office or other outpatient visit, 30-39 minutes | 217 | 122 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 169 | 72 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 102 | 15 |
| Blood test, comprehensive group of blood chemicals | 86 | 15 |
| Blood creatinine level | 60 | 56 |
| Established patient office or other outpatient visit, 20-29 minutes | 38 | 26 |
| Ct scan of abdomen and pelvis with contrast | 21 | 19 |
| Ct scan of chest with contrast | 19 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Letrozole Other prescribers in Dallas, TX | 62 |
| Terconazole | 19 |
| Metronidazole Other prescribers in Dallas, TX | 16 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Dallas, TX | 13 |
| Olanzapine Other prescribers in Dallas, TX | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 11 payments worth $841 in total to this clinician.
| Dilon Technologies, Inc. | $386 |
|---|---|
| Ethicon US, LLC | $178 |
| Caris Mpi, Inc. | $152 |
| Myriad Genetic Laboratories, Inc. | $106 |
| Genmab U.S., Inc. | $19.77 |
| Food and Beverage | $822 |
|---|---|
| Education | $19.77 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genmab U.S., Inc. Apr 23, 2025 | Education Tivdak · Oncology · in-kind | $19.77 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.